Primary Care
Vaccines
More in Vaccines
Arexvy now approved for people 50 years and older at increased risk of serious outcomes
Jun 10, 2024
But public acceptance of a vaccine requiring multiple boosters could be problematic, experts say
Jun 05, 2024
Independent reviewers reject causal links to infertility, myocardial infarction, stroke
Apr 16, 2024
Panelists from companies making such vaccines see "enormous" benefit, others are more skeptical
Apr 04, 2024